Nuo Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020 - 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2020 - 2016
Net Income	-2.51	-2.32	-3.17	-3.17	-0.09	Upgrade
Depreciation & Amortization	0.16	0.1	0.11	0.07	-	Upgrade
Stock-Based Compensation	0.14	0.06	0.02	0.01	0.01	Upgrade
Provision & Write-off of Bad Debts	0.09	0.08	0.16	-	-	Upgrade
Other Operating Activities	0.02	-0.1	0.02	-0.15	-	Upgrade
Change in Accounts Receivable	-0.4	-0.08	-0.32	-0.09	-	Upgrade
Change in Inventory	-0.08	0.03	0.01	-0.24	-	Upgrade
Change in Accounts Payable	0.22	-0.04	-0	0.02	0.01	Upgrade
Change in Unearned Revenue	1.28	-	-	-	-	Upgrade
Change in Other Net Operating Assets	0.24	0.05	0.01	-0.16	-0.05	Upgrade
Operating Cash Flow	-0.86	-2.23	-3.17	-3.71	-0.12	Upgrade
Capital Expenditures	-0.27	-0.15	-0.01	-0.06	-	Upgrade
Investing Cash Flow	-0.27	-0.15	-0.01	-0.06	-	Upgrade
Short-Term Debt Issued	0.5	-	-	-	-	Upgrade
Total Debt Issued	0.5	-	-	-	-	Upgrade
Net Debt Issued (Repaid)	0.5	-	-	-	-	Upgrade
Issuance of Common Stock	0.9	1.74	2	4.46	1.37	Upgrade
Financing Cash Flow	1.4	1.74	2	4.46	1.37	Upgrade
Miscellaneous Cash Flow Adjustments	-	-	-0	-	-	Upgrade
Net Cash Flow	0.27	-0.64	-1.18	0.69	1.25	Upgrade
Free Cash Flow	-1.14	-2.39	-3.18	-3.77	-0.12	Upgrade
Free Cash Flow Margin	-34.40%	-174.82%	-521.76%	-3355.12%	-	Upgrade
Free Cash Flow Per Share	-0.02	-0.05	-0.07	-0.09	-0.00	Upgrade
Cash Interest Paid	0	0	0	0	-	Upgrade
Levered Free Cash Flow	-1.11	-1.53	-1.85	-2.74	-0.09	Upgrade
Unlevered Free Cash Flow	-1.11	-1.53	-1.85	-2.74	-0.09	Upgrade
Change in Working Capital	1.24	-0.04	-0.3	-0.47	-0.04	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.